Cargando…

Studying the effects of booster shots and antibody responses to the SARS-CoV-2 vaccination over time in health personnel

BACKGROUND: With the emergence of mutant versions that lead to continual spreading and recurrent infections of SARS-CoV-2, the COVID-19 vaccines can assist protection for high risk groups, particularly health workers. Even while booster shots have been widely used, longitude studies on immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jingjing, Mu, Hanyou, Pan, Xiaowan, Guo, Wenzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060948/ https://www.ncbi.nlm.nih.gov/pubmed/37009493 http://dx.doi.org/10.3389/fcimb.2023.1138631

Ejemplares similares

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
por: Choi, Ju-yeon, et al.
Publicado: (2022)

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Longitudinal anti-SARS-CoV-2 antibody immune response in acute and convalescent patients
por: Pérez-Juárez, Horacio, et al.
Publicado: (2023)

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody
por: Li, Yizhe, et al.
Publicado: (2023)

Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces
por: Wu, Wenrui, et al.
Publicado: (2022)

Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Lee, Beomki, et al.
Publicado: (2022)

No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection
por: García-Nicolás, Obdulio, et al.
Publicado: (2021)

Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine
por: Zhang, Yuwei, et al.
Publicado: (2022)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects
por: Ferrari, Luca, et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Development of an Adeno-Associated Virus-Vectored SARS-CoV-2 Vaccine and Its Immunogenicity in Mice
por: Qin, Xi, et al.
Publicado: (2022)

Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023)

Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
por: Zhao, Lili, et al.
Publicado: (2021)

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant
por: Wu, Jiajun, et al.
Publicado: (2022)

Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
por: Beddingfield, Brandon J., et al.
Publicado: (2021)

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection
por: Li, Tao, et al.
Publicado: (2020)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 in the First Batch of COVID-19 Patients in China by a Self-Developed Rapid IgM-IgG Test
por: Pu, Yiyi, et al.
Publicado: (2022)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

SARS-CoV-2: The Monster Causes COVID-19
por: Song, Chang, et al.
Publicado: (2022)

SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
por: Ning, Shuo, et al.
Publicado: (2021)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Liu, Yijun, et al.
Publicado: (2021)

Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects
por: Zhang, Jiaqi, et al.
Publicado: (2021)

Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches
por: Marriam, Saigha, et al.
Publicado: (2023)

Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2
por: Alam, Intikhab, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
por: Periwal, Neha, et al.
Publicado: (2022)

SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
por: Chaubey, Ishaan, et al.
Publicado: (2021)

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
por: Liu, Fengming, et al.
Publicado: (2021)

microRNA, the Innate-Immune System and SARS-CoV-2
por: Hill, James M., et al.
Publicado: (2022)

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador
por: Guevara, Rommel, et al.
Publicado: (2022)

SARS-CoV-2 induced hepatic injuries and liver complications
por: Saeed, Umar, et al.
Publicado: (2022)

Choosing a cellular model to study SARS-CoV-2
por: Pires De Souza, Gabriel Augusto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c6hubf7o10sonn0v6ss8ejfs06